Cargando…
Systemic lupus erythematosus and COVID-19 during pregnancy
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is currently lacking. Methods: Herein, we...
Autores principales: | Smeele, Hieronymus TW, Perez-Garcia, Luis F, Grimminck, Koen, Schoenmakers, Sam, Mulders, Annemarie GMGJ, Dolhain, Radboud JEM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120627/ https://www.ncbi.nlm.nih.gov/pubmed/33715506 http://dx.doi.org/10.1177/09612033211002270 |
Ejemplares similares
-
Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022) -
Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients’ offspring
por: Smeele, Hieronymus T W, et al.
Publicado: (2022) -
Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study
por: Smeele, Hieronymus TW, et al.
Publicado: (2021) -
IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive
por: Bongenaar, Margot, et al.
Publicado: (2020) -
Biological and Methotrexate Survival after Pregnancy in Patients With a Rheumatic Disease
por: Tahmasian, Helena, et al.
Publicado: (2022)